SIBN News and Press, SI-BONE Inc. From 02/19/20

SANTA CLARA, Calif. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter of 2019 after market close o...

SI-BONE (NASDAQ: SIBN ) has priced its public offering of 4.3M common shares at $21.50 per share, ~1.8M shares from selling stockholders and ~2.5M from the company. More news on: SI-BONE, Inc., Healthcare stocks news, , Read more ...

SANTA CLARA, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the pricing of its public offering of 4,300...

SI-BONE (NASDAQ: SIBN ) commences a public offering of 4.3M common shares, ~1.8M from selling stockholders and ~2.5M from the company. More news on: SI-BONE, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

SANTA CLARA, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that it has commenced an underwritten publi...

SI-BONE ( SIBN +4.3% ) expects Q4 revenues in the range of  $19.5M-19.8M (+25-27% Y/Y) vs. a consensus of $18.64M. SIBN expects full year 2020 revenue to be in the range of $80M -$82M (~+19%-22%) vs. a consensus $81.46M. More news on: SI-BONE, Inc., Healthcare stocks news, ...

SANTA CLARA, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced preliminary unaudited revenue for the fourth quarter and full year 2019. Prelimina...

NuVasive (NASDAQ: NUVA ) initiated with Buy rating and $93 (19% upside) price target at SunTrust. More news on: NuVasive, Inc., OrthoPediatrics Corp., PerkinElmer, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Allogene Therapeutics (NASDAQ: ALLO ) initiated with Market Perform rating and $37 (36% upside) price target at JMP Securities. More news on: Allogene Therapeutics, Inc., CorMedix, Inc., Fortress Biotech, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

SANTA CLARA, Calif., Dec. 13, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that CIGNA has established a positive coverage policy for minimally ...